Data Shows Majority of US Users Discontinue 'Miracle' Weight-loss Drugs
Friday, 12 July 2024, 08:15
Weight-loss Drugs Facing Scrutiny
The high cost of weight-loss drugs like Ozempic and Zepbound has drawn criticism from President Biden.
User Discontinuation Rates
Data indicates that a majority of users in the US stop taking these 'miracle' medications within two years.
Challenges in Long-term Adherence
Questions arise regarding the sustainability and effectiveness of these drugs for managing obesity.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.